173 related articles for article (PubMed ID: 20822802)
1. Immunization with synthetic VEGF peptides in ovarian cancer.
Wang B; Kaumaya PT; Cohn DE
Gynecol Oncol; 2010 Dec; 119(3):564-70. PubMed ID: 20822802
[TBL] [Abstract][Full Text] [Related]
2. Soluble production and function of vascular endothelial growth factor/basic fibroblast growth factor complex peptide.
Zhang Q; Lao X; Huang J; Zhu Z; Pang L; Tang Y; Song Q; Huang J; Deng J; Deng N; Yang Q; Sengupta AM; Xiong L
Biotechnol Prog; 2015; 31(1):194-203. PubMed ID: 25271020
[TBL] [Abstract][Full Text] [Related]
3. Peptide vaccines of the HER-2/neu dimerization loop are effective in inhibiting mammary tumor growth in vivo.
Allen SD; Garrett JT; Rawale SV; Jones AL; Phillips G; Forni G; Morris JC; Oshima RG; Kaumaya PT
J Immunol; 2007 Jul; 179(1):472-82. PubMed ID: 17579068
[TBL] [Abstract][Full Text] [Related]
4. VEGF kinoid vaccine, a therapeutic approach against tumor angiogenesis and metastases.
Rad FH; Le Buanec H; Paturance S; Larcier P; Genne P; Ryffel B; Bensussan A; Bizzini B; Gallo RC; Zagury D; Uzan G
Proc Natl Acad Sci U S A; 2007 Feb; 104(8):2837-42. PubMed ID: 17301234
[TBL] [Abstract][Full Text] [Related]
5. L-5F, an apolipoprotein A-I mimetic, inhibits tumor angiogenesis by suppressing VEGF/basic FGF signaling pathways.
Gao F; Vasquez SX; Su F; Roberts S; Shah N; Grijalva V; Imaizumi S; Chattopadhyay A; Ganapathy E; Meriwether D; Johnston B; Anantharamaiah GM; Navab M; Fogelman AM; Reddy ST; Farias-Eisner R
Integr Biol (Camb); 2011 Apr; 3(4):479-89. PubMed ID: 21283904
[TBL] [Abstract][Full Text] [Related]
6. Utilizing VEGF165b mutant as an effective immunization adjunct to augment antitumor immune response.
Zhang H; Jia E; Xia W; Lv T; Lu C; Xu Z; Zhu W
Vaccine; 2019 Apr; 37(15):2090-2098. PubMed ID: 30837171
[TBL] [Abstract][Full Text] [Related]
7. VEGF antibody plus cisplatin reduces angiogenesis and tumor growth in a xenograft model of ovarian cancer.
Ghosh S; Maity P
J Environ Pathol Toxicol Oncol; 2010; 29(1):17-30. PubMed ID: 20528744
[TBL] [Abstract][Full Text] [Related]
8. Paris Saponin II suppresses the growth of human ovarian cancer xenografts via modulating VEGF-mediated angiogenesis and tumor cell migration.
Xiao X; Yang M; Xiao J; Zou J; Huang Q; Yang K; Zhang B; Yang F; Liu S; Wang H; Bai P
Cancer Chemother Pharmacol; 2014 Apr; 73(4):807-18. PubMed ID: 24638862
[TBL] [Abstract][Full Text] [Related]
9. Experimental studies of a vaccine formulation of recombinant human VEGF antigen with aluminum phosphate.
Pérez Sánchez L; Morera Díaz Y; Bequet-Romero M; Ramses Hernández G; Rodríguez Y; Castro Velazco J; Puente Pérez P; Ayala Avila M; Gavilondo JV
Hum Vaccin Immunother; 2015; 11(8):2030-7. PubMed ID: 25891359
[TBL] [Abstract][Full Text] [Related]
10. Peptide vaccines and peptidomimetics of EGFR (HER-1) ligand binding domain inhibit cancer cell growth in vitro and in vivo.
Foy KC; Wygle RM; Miller MJ; Overholser JP; Bekaii-Saab T; Kaumaya PT
J Immunol; 2013 Jul; 191(1):217-27. PubMed ID: 23698748
[TBL] [Abstract][Full Text] [Related]
11. Targeting the pro-angiogenic forms of VEGF or inhibiting their expression as anti-cancer strategies.
Guyot M; Hilmi C; Ambrosetti D; Merlano M; Lo Nigro C; Durivault J; Grépin R; Pagès G
Oncotarget; 2017 Feb; 8(6):9174-9188. PubMed ID: 27999187
[TBL] [Abstract][Full Text] [Related]
12. Targeted vaccination against the bevacizumab binding site on VEGF using 3D-structured peptides elicits efficient antitumor activity.
Wentink MQ; Hackeng TM; Tabruyn SP; Puijk WC; Schwamborn K; Altschuh D; Meloen RH; Schuurman T; Griffioen AW; Timmerman P
Proc Natl Acad Sci U S A; 2016 Nov; 113(44):12532-12537. PubMed ID: 27791128
[TBL] [Abstract][Full Text] [Related]
13. Synthesized multiple antigenic polypeptide vaccine based on B-cell epitopes of human heparanase could elicit a potent antimetastatic effect on human hepatocellular carcinoma in vivo.
Zhang J; Yang JM; Wang HJ; Ru GQ; Fan DM
PLoS One; 2013; 8(1):e52940. PubMed ID: 23308126
[TBL] [Abstract][Full Text] [Related]
14. Anti-flt1 peptide, a vascular endothelial growth factor receptor 1-specific hexapeptide, inhibits tumor growth and metastasis.
Bae DG; Kim TD; Li G; Yoon WH; Chae CB
Clin Cancer Res; 2005 Apr; 11(7):2651-61. PubMed ID: 15814646
[TBL] [Abstract][Full Text] [Related]
15. B-cell epitope peptide vaccination targeting dimer interface of epidermal growth factor receptor (EGFR).
Zhu L; Zhao L; Wu M; Chen Z; Li H
Immunol Lett; 2013 Jun; 153(1-2):33-40. PubMed ID: 23871733
[TBL] [Abstract][Full Text] [Related]
16. Antiangiogenic Vascular Endothelial Growth Factor-Blocking Peptides Displayed on the Capsid of an Infectious Oncolytic Parvovirus: Assembly and Immune Interactions.
Grueso E; Sánchez-Martínez C; Calvo-López T; de Miguel FJ; Blanco-Menéndez N; Fernandez-Estevez M; Elizalde M; Sanchez J; Kourani O; Martin D; Tato A; Guerra M; Andrés G; Almendral JM
J Virol; 2019 Oct; 93(19):. PubMed ID: 31315994
[TBL] [Abstract][Full Text] [Related]
17. A chimeric multi-human epidermal growth factor receptor-2 B cell epitope peptide vaccine mediates superior antitumor responses.
Dakappagari NK; Pyles J; Parihar R; Carson WE; Young DC; Kaumaya PT
J Immunol; 2003 Apr; 170(8):4242-53. PubMed ID: 12682258
[TBL] [Abstract][Full Text] [Related]
18. Multiple antigenic polypeptide composed of heparanase B‑cell epitopes shrinks human hepatocellular carcinoma in mice.
Zhang J; Yang J; Cai Y; Jin N; Wang H; Yu T
Oncol Rep; 2015 Mar; 33(3):1248-56. PubMed ID: 25522727
[TBL] [Abstract][Full Text] [Related]
19. Sulfated fucoidan FP08S2 inhibits lung cancer cell growth in vivo by disrupting angiogenesis via targeting VEGFR2/VEGF and blocking VEGFR2/Erk/VEGF signaling.
Chen H; Cong Q; Du Z; Liao W; Zhang L; Yao Y; Ding K
Cancer Lett; 2016 Nov; 382(1):44-52. PubMed ID: 27569654
[TBL] [Abstract][Full Text] [Related]
20. Mapping T and B cell epitopes in sperm protein 17 to support the development of an ovarian cancer vaccine.
Xiang SD; Gao Q; Wilson KL; Heyerick A; Plebanski M
Vaccine; 2015 Nov; 33(44):5950-9. PubMed ID: 26263201
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]